-
公开(公告)号:MA37943B1
公开(公告)日:2016-11-30
申请号:MA37943
申请日:2015-03-20
Applicant: HOFFMANN LA ROCHE , HOFFMANN-LA ROCHE INC
Inventor: BRUNNER DANIELA , MALBERG JESSICA , SHANKAR BAVANI G , KOLCZEWSKI SABINE , LIMBERG ANJA , PRINSSEN ERIC , RIEMER CLAUS , STOLL THEODOR
IPC: A61K31/404 , A61K31/4178 , A61K31/437 , A61K31/44 , A61K31/506 , A61P25/00 , C07D209/34 , C07D401/12 , C07D401/14 , C07D403/12 , C07D471/04
Abstract: La présente invention concerne des 2-oxo-2,3-dihydro-indoles de formule générale (i) dans laquelle (n
-
公开(公告)号:CA2915536C
公开(公告)日:2021-10-19
申请号:CA2915536
申请日:2014-06-16
Applicant: HOFFMANN LA ROCHE
Inventor: BRUNNER DANIELA , HILPERT HANS , KOLCZEWSKI SABINE , LIMBERG ANJA , MALBERG JESSICA , PRINSSEN ERIC , RIEMER CLAUS , SHANKAR BAVANI G , STOLL THEODOR
IPC: C07D405/14 , A61K31/44 , A61K31/4402 , A61K31/4406 , A61K31/4409 , A61P25/00 , C07D401/04 , C07D403/04 , C07D413/04 , C07D413/14 , C07D417/04 , C07D471/04 , C07D487/04 , C07D498/04 , C07H19/044
Abstract: The present invention is concerned with 2-oxo-2,3-dihydro-indoles of general formula (I) wherein Ar is a heteroaryl group, containing one, two or three heteroatoms, selected from N, S or O; R1 is hydrogen, lower alkyl, halogen, amino, dimethylamino, cyano, lower alkyl substituted by halogen, lower alkyl substituted by hydroxy, CH(OH)CF3, (CH2)o-lower alkoxy, cycloalkyl optionally substituted by CF3, or heterocycloalkyl optionally substituted by lower alkyl; R2 is hydrogen, lower alkyl, (CH2)o-cycloalkyl, (CH2)o-O-cycloalkyl, (CH2)o-lower alkoxy, CH2)o-lower alkoxy substituted by halogen, (CH2)o-heterocycloalkyl optionally substituted by lower alkyl, (CH2)o-S(O)2-cycloalkyl, lower alkyl substituted by one or two hydroxy, lower alkyl substituted by one or two lower alkoxy, (CH2)o-S(O)2-lower alkyl, lower alkyl substituted by halogen or CH2CH(OH)CF3; R3 is halogen or lower alkyl; X is CH or N; X1 is CH or N; n is 1 or 2; o is 0, 1, 2 or 3; m is 0, 1 or 2; and the dotted line is a bond or not; as well as with a pharmaceutically acceptable salts thereof, with a racemic mixture, or with its corresponding enantiomer and/or optical isomer and/or stereoisomer thereof The compounds may be used for the treatment of certain central nervous system disorders which are positive (psychosis) and negative symptoms of schizophrenia, substance abuse, alcohol and drug addiction, obsessive-compulsive disorders, cognitive impairment, bipolar disorders, mood disorders, major depression, treatment resistant depression, anxiety disorders, Alzheimer's disease, autism, Parkinson's disease, chronic pain, borderline personality disorder, sleep disturbances, chronic fatigue syndrome, stiffness, antiinflammatory effects in arthritis and balance problems.
-
公开(公告)号:ES2590531T3
公开(公告)日:2016-11-22
申请号:ES13759241
申请日:2013-09-10
Applicant: HOFFMANN LA ROCHE
Inventor: BRUNNER DANIELA , MALBERG JESSICA , SHANKAR BAVANI G , KOLCZEWSKI SABINE , LIMBERG ANJA , PRINSSEN ERIC , RIEMER CLAUS , STOLL THEODOR
IPC: C07D403/12 , A61K31/404 , A61K31/4178 , A61K31/437 , A61K31/44 , A61K31/506 , A61P25/00 , C07D209/34 , C07D401/12 , C07D401/14 , C07D471/04
Abstract: Un compuesto de fórmula**Fórmula** en la que:**Fórmula** es fenilo o un grupo heteroarilo, seleccionado de piridinilo, pirimidinilo, imidazolilo, isoxazolilo o pirazolilo;**Fórmula** es fenilo o piridinilo, en el que el átomo de N del grupo piridinilo puede estar en todas las posiciones libres; R1 es hidrógeno, alquilo C1-7, alquilo C1-7 sustituido con halógeno, alcoxi C1-7 o halógeno; n es 1 o 2; si n es 2, R1 puede ser el mismo o no; R2/R2' son independientemente entre sí alquilo C1-7 o forman junto con el átomo de carbono al que están unidos un anillo cicloalquilo C3-6; R3 es alquilo C1-7, cicloalquilo C3-6, CH2-cicloalquilo C3-6, cicloalquilo C3-6 en el que un átomo de carbono del anillo se reemplaza por -O-, (CH2)3-O-cicloalquilo C3-6, alquilo C1-7 sustituido con hidroxi, alquilo C1-7 sustituido con halógeno, (CH2)3-S(O)2-cicloalquilo C3-6 o (CH2)2-S(O)2-alquilo C1-7; R4 es hidrógeno, halógeno o alquilo C1-7; m es 1 o 2; si m es 2, R4 puede ser el mismo o no; así como con las sales farmacéuticamente aceptables de los mismos, con una mezcla racémica o con los enantiómeros correspondientes y/o isómeros ópticos y/o estereoisómeros de los mismos.
-
公开(公告)号:SG11201501923WA
公开(公告)日:2015-04-29
申请号:SG11201501923W
申请日:2013-09-10
Applicant: HOFFMANN LA ROCHE
Inventor: BRUNNER DANIELA , MALBERG JESSICA , SHANKAR BAVANI G , KOLCZEWSKI SABINE , LIMBERG ANJA , PRINSSEN ERIC , RIEMER CLAUS , STOLL THEODOR
IPC: C07D403/12 , A61K31/404 , A61K31/4178 , A61K31/437 , A61K31/44 , A61K31/506 , A61P25/00 , C07D209/34 , C07D401/12 , C07D401/14 , C07D471/04
Abstract: The present invention is concerned with 2-oxo-2,3-dihydro-indoles of general formula wherein is phenyl or a heteroaryl group, selected from pyridinyl, pyrimidinyl, imidazolyl, isoxazolyl or pyrazolyl; is phenyl or pyridinyl, wherein the N atom in the pyridinyl group may be on all free positions; R1 is hydrogen, lower alkyl, lower alkyl substituted by halogen, lower alkoxy or halogen; n is 1 or 2; if n is 2, R1 may be the same or not; R2/R2′ are independently from each other lower alkyl, or form together with the carbon atom to which they are attached a C3-6-cycloalkyl ring; R3 is lower alkyl, C3-6-cycloalkyl, CH2—C3-6-cycloalkyl, C3-6-cycloalkyl wherein one ring-carbon atom is replaced by —O—, (CH2)3—O—C3-6-cycloalkyl, lower alkyl substituted by hydroxy, lower alkyl substituted by halogen, (CH2)3—S(O)2—C3-6-cycloalkyl or (CH2)2—S(O)2-lower alkyl; R4 is hydrogen, halogen or lower alkyl; m is 1 or 2; if m is 2, R4 may be the same or not; as well as with a pharmaceutically acceptable salts thereof, with a racemic mixture, or with its corresponding enantiomer and/or optical isomer and/or stereoisomer thereof.
-
公开(公告)号:AU2013314417B2
公开(公告)日:2016-01-21
申请号:AU2013314417
申请日:2013-09-10
Applicant: HOFFMANN LA ROCHE
Inventor: BRUNNER DANIELA , MALBERG JESSICA , SHANKAR BAVANI G , KOLCZEWSKI SABINE , LIMBERG ANJA , PRINSSEN ERIC , RIEMER CLAUS , STOLL THEODOR
IPC: C07D403/12 , A61K31/404 , A61K31/4178 , A61K31/437 , A61K31/44 , A61K31/506 , A61P25/00 , C07D209/34 , C07D401/12 , C07D401/14 , C07D471/04
Abstract: The present invention is concerned with 2-oxo-2,3-dihydro-indoles of general formula (I) wherein (N
-
公开(公告)号:HK1206721A1
公开(公告)日:2016-01-15
申请号:HK15107160
申请日:2015-07-27
Applicant: HOFFMANN LA ROCHE
Inventor: BRUNNER DANIELA , MALBERG JESSICA , SHANKAR BAVANI G G , KOLCZEWSKI SABINE , LIMBERG ANJA , PRINSSEN ERIC , RIEMER CLAUS , STOLL THEODER
IPC: C07D20060101 , A61K20060101 , A61P20060101
Abstract: The present invention is concerned with 2-oxo-2,3-dihydro-indoles of general formula wherein is phenyl or a heteroaryl group, selected from pyridinyl, pyrimidinyl, imidazolyl, isoxazolyl or pyrazolyl; is phenyl or pyridinyl, wherein the N atom in the pyridinyl group may be on all free positions; R1 is hydrogen, lower alkyl, lower alkyl substituted by halogen, lower alkoxy or halogen; n is 1 or 2; if n is 2, R1 may be the same or not; R2/R2′ are independently from each other lower alkyl, or form together with the carbon atom to which they are attached a C3-6-cycloalkyl ring; R3 is lower alkyl, C3-6-cycloalkyl, CH2—C3-6-cycloalkyl, C3-6-cycloalkyl wherein one ring-carbon atom is replaced by —O—, (CH2)3—O—C3-6-cycloalkyl, lower alkyl substituted by hydroxy, lower alkyl substituted by halogen, (CH2)3—S(O)2—C3-6-cycloalkyl or (CH2)2—S(O)2-lower alkyl; R4 is hydrogen, halogen or lower alkyl; m is 1 or 2; if m is 2, R4 may be the same or not; as well as with a pharmaceutically acceptable salts thereof, with a racemic mixture, or with its corresponding enantiomer and/or optical isomer and/or stereoisomer thereof.
-
公开(公告)号:CL2015000559A1
公开(公告)日:2015-07-10
申请号:CL2015000559
申请日:2015-03-06
Applicant: HOFFMANN LA ROCHE
Inventor: KOLCZEWSKI SABINE , LIMBERG ANJA , BRUNNER DANIELA , MALBERG JESSICA , SHANKAR BAVANI G , PRINSSEN ERIC , RIEMER CLAUS , STOLL THEODOR
IPC: C07D209/34 , A61K31/404 , A61K31/4178 , A61K31/4439 , A61K31/444 , A61P25/00 , C07D401/12 , C07D401/14 , C07D403/12 , C07D471/04
-
公开(公告)号:PE20150943A1
公开(公告)日:2015-06-20
申请号:PE2015000365
申请日:2013-09-10
Applicant: HOFFMANN LA ROCHE
Inventor: BRUNNER DANIELA , MALBERG JESSICA , SHANKAR BAVANI G , KOLCZEWSKI SABINE , LIMBERG ANJA , PRINSSEN ERIC , RIEMER CLAUS , STOLL THEODOR
IPC: C07D403/12 , A61K31/404 , A61K31/4178 , A61K31/437 , A61K31/44 , A61K31/506 , A61P25/00 , C07D209/34 , C07D401/12 , C07D401/14 , C07D471/04
Abstract: Referida a derivados de 2-oxo-2,3-dihidroindoles de la formula general (I), donde N1 es fenilo, piridinilo, pirimidinilo, imidazolilo, isoxazolilo o pirazolilo; N2 es fenilo o piridinilo; R1 es hidrogeno, alquilo C1-C7, alquilo C1-C7 sustituido por halogeno, alcoxi C1-C7 o halogeno; n es 1 o 2; R1 y R2 son alquilo C1-C7 o junto con el atomo de carbono, al que estan unidos, forman un anillo cicloalquilo C3-6; R3 es alquilo C1-C7, cicloalquilo C3-6, CH2-cicloalquilo C3-6, cicloalquilo C3-6, entre otros; R4 es hidrogeno, halogeno o alquilo C1-C7; m es 1 o 2. Dichos compuestos son utiles en el tratamiento de trastornos del sistema nervioso central tales como el abuso de sustancias, adiccion al alcohol y drogas, trastornos obsesivos-compulsivos, desequilibrio cognitivo, entre otros
-
公开(公告)号:CA2883817C
公开(公告)日:2017-09-05
申请号:CA2883817
申请日:2013-09-10
Applicant: HOFFMANN LA ROCHE
Inventor: BRUNNER DANIELA , MALBERG JESSICA , SHANKAR BAVANI G , KOLCZEWSKI SABINE , LIMBERG ANJA , PRINSSEN ERIC , RIEMER CLAUS , STOLL THEODOR
IPC: C07D403/12 , A61K31/404 , A61K31/4178 , A61K31/437 , A61K31/44 , A61K31/506 , A61P25/00 , C07D209/34 , C07D401/12 , C07D401/14 , C07D471/04
Abstract: The present invention is concerned with 2-oxo-2,3-dihydro-indoles of general formula (I) wherein N1, N2, R1, R2/R2', R3 and R4 are as defined herein, as well as with a pharmaceutically acceptable salts thereof, with a racemic mixture, or with its corresponding enantiomer and/or optical isomer and/or stereoisomer thereof; and their use for the treatment of a central nervous system disorder.
-
公开(公告)号:PE09432015A1
公开(公告)日:2015-06-20
申请号:PE0003652015
申请日:2013-09-10
Applicant: HOFFMANN LA ROCHE
Inventor: BRUNNER DANIELA , MALBERG JESSICA , SHANKAR BAVANI G , KOLCZEWSKI SABINE , LIMBERG ANJA , PRINSSEN ERIC , RIEMER CLAUS , STOLL THEODOR
IPC: C07D403/12 , A61K31/404 , A61K31/4178 , A61K31/437 , A61K31/44 , A61K31/506 , A61P25/00 , C07D209/34 , C07D401/12 , C07D401/14 , C07D471/04
CPC classification number: C07D471/04 , A61K31/4439 , A61K31/444 , A61K31/506 , A61K45/06 , C07D209/34 , C07D401/12 , C07D401/14 , C07D403/12 , C07D405/14
Abstract: Referida a derivados de 2-oxo-2,3-dihidroindoles de la formula general (I), donde N1 es fenilo, piridinilo, pirimidinilo, imidazolilo, isoxazolilo o pirazolilo; N2 es fenilo o piridinilo; R1 es hidrogeno, alquilo C1-C7, alquilo C1-C7 sustituido por halogeno, alcoxi C1-C7 o halogeno; n es 1 o 2; R1 y R2 son alquilo C1-C7 o junto con el atomo de carbono, al que estan unidos, forman un anillo cicloalquilo C3-6; R3 es alquilo C1-C7, cicloalquilo C3-6, CH2-cicloalquilo C3-6, cicloalquilo C3-6, entre otros; R4 es hidrogeno, halogeno o alquilo C1-C7; m es 1 o 2. Dichos compuestos son utiles en el tratamiento de trastornos del sistema nervioso central tales como el abuso de sustancias, adiccion al alcohol y drogas, trastornos obsesivos-compulsivos, desequilibrio cognitivo, entre otros
-
-
-
-
-
-
-
-
-